The Global Initiative for Asthma (GINA) has played a leading role in disseminating information about asthma care since its formation in 1993. The 2006 GINA report emphasizes the importance of asthma control rather than severity in treatment decisions, and highlights the need for a partnership between patients and healthcare providers, along with guided self-management and setting treatment goals. The report also addresses the implementation of asthma guidelines in health systems, considering local conditions and resource availability. It provides updated scientific information and recommendations for asthma management, including classification, diagnosis, treatment options, and monitoring. The report emphasizes the role of inhaled corticosteroids as the most effective controller therapy and discusses the use of other medications such as leukotriene modifiers, long-acting β2-agonists, and systemic corticosteroids. It also covers the diagnosis and classification of asthma, the burden of asthma, and the factors influencing its development and expression. The report aims to improve asthma control and reduce the global burden of this chronic disease.The Global Initiative for Asthma (GINA) has played a leading role in disseminating information about asthma care since its formation in 1993. The 2006 GINA report emphasizes the importance of asthma control rather than severity in treatment decisions, and highlights the need for a partnership between patients and healthcare providers, along with guided self-management and setting treatment goals. The report also addresses the implementation of asthma guidelines in health systems, considering local conditions and resource availability. It provides updated scientific information and recommendations for asthma management, including classification, diagnosis, treatment options, and monitoring. The report emphasizes the role of inhaled corticosteroids as the most effective controller therapy and discusses the use of other medications such as leukotriene modifiers, long-acting β2-agonists, and systemic corticosteroids. It also covers the diagnosis and classification of asthma, the burden of asthma, and the factors influencing its development and expression. The report aims to improve asthma control and reduce the global burden of this chronic disease.